M-Pap

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the reduction of fever and the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, backache, arthritis, the common cold, toothache, and menstrual cramps.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are advised to take 3 teaspoonfuls (15 mL) every 5 hours. The total daily dosage should not exceed 15 teaspoonfuls (75 mL) within a 24-hour period.

For children under 12 years of age, administration should occur only under the direct guidance of a licensed healthcare professional, such as a doctor or pharmacist. It is essential to follow the specific recommendations provided by the healthcare provider regarding the appropriate dosage and frequency for this age group.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should not use this product in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. Additionally, individuals with a known allergy to acetaminophen or any of the inactive ingredients in this formulation should avoid its use.

Furthermore, the product should not be used for pain relief for more than 10 days or for fever for more than 3 days unless directed by a healthcare professional.

Warnings and Precautions

This product contains acetaminophen, which carries significant risks that healthcare professionals must communicate to patients.

Liver Warning Severe liver damage may occur if the maximum daily dosage of 8 teaspoonfuls (40 mL) is exceeded within a 24-hour period. Additionally, the risk of liver damage increases if acetaminophen is taken concurrently with other medications containing acetaminophen or if the patient consumes three or more alcoholic drinks daily while using this product.

Allergy Alert Acetaminophen may lead to severe skin reactions. Symptoms indicative of such reactions include skin reddening, blisters, and rash. Should any of these symptoms occur, it is imperative to discontinue use immediately and seek medical assistance.

Sore Throat Warning In cases of severe sore throat that persists for more than two days or is accompanied by fever, headache, rash, nausea, or vomiting, patients should be advised to consult a physician promptly.

General Precautions Patients should be encouraged to consult a healthcare provider prior to use if they have any underlying health conditions, particularly liver disease. Furthermore, it is advisable to seek guidance from a doctor or pharmacist if the patient is currently taking other medications, including blood thinners such as warfarin.

Emergency Medical Help In the event of an overdose, immediate medical attention is crucial. Patients should be instructed to contact a Poison Control Center or seek emergency medical help without delay, even if no signs or symptoms are initially apparent.

Discontinuation and Consultation Patients should be advised to stop taking the product and consult a healthcare professional if they experience new symptoms such as rash, hives, itching, or hoarseness; if redness or swelling occurs; if pain worsens or persists beyond ten days; if fever intensifies or lasts more than three days; or if symptoms do not improve. These may be indicative of a serious condition requiring medical evaluation.

Side Effects

Severe liver damage may occur in patients who exceed the maximum daily amount of 8 teaspoonfuls (40 mL) within 24 hours, take the product in conjunction with other drugs containing acetaminophen, or consume three or more alcoholic drinks daily while using this product.

Patients should be aware that acetaminophen may cause severe skin reactions, which can manifest as skin reddening, blisters, or rash. If any of these symptoms occur, it is imperative to discontinue use and seek medical assistance immediately.

In cases of severe sore throat that persists for more than two days or is accompanied by fever, headache, rash, nausea, or vomiting, patients are advised to consult a doctor promptly.

The product should not be used in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription, unless confirmed by a healthcare professional. Additionally, it should not be used for more than 10 days for pain or more than 3 days for fever unless directed by a physician. Patients with known allergies to acetaminophen or any inactive ingredients in the product should avoid its use.

Before using this product, patients with health issues, particularly liver disease, should consult a doctor. Furthermore, it is recommended that patients ask a doctor or pharmacist before use if they are taking other medications, including blood thinners such as warfarin.

While using this product, patients must adhere to the recommended dosage to avoid overdose. They should discontinue use and consult a doctor if new symptoms arise, such as rash, hives, itching, or hoarseness, or if redness or swelling occurs. Additionally, if pain worsens or lasts longer than 10 days, or if fever worsens or persists beyond 3 days, medical advice should be sought. These symptoms may indicate a serious condition.

In the event of an overdose, which may lead to liver damage, patients should seek medical help or contact a Poison Control Center immediately. Prompt medical attention is critical, even if no signs or symptoms are initially apparent.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking other drugs, particularly anticoagulants such as warfarin. The combination may necessitate careful monitoring due to potential pharmacodynamic interactions that could increase the risk of bleeding. Adjustments to the dosage of either medication may be required based on clinical judgment and patient response.

Packaging & NDC

Below are the non-prescription pack sizes of M-Pap (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should use this medication only under the direct guidance of a licensed healthcare professional, such as a doctor or pharmacist.

For adolescents aged 12 years and older, the recommended dosage is 3 teaspoonfuls (15 mL) every 5 hours, with a maximum limit of 15 teaspoonfuls (75 mL) within a 24-hour period.

Geriatric Use

Elderly patients should consult a healthcare provider prior to use, particularly if they have pre-existing health conditions, especially liver disease.

For adults and children aged 12 years and older, the recommended dosage is 3 teaspoonfuls (15 mL) every 5 hours, with a maximum limit of 15 teaspoonfuls (75 mL) within a 24-hour period.

It is important to note that for children under 12 years of age, administration should occur only under the direct guidance of a licensed healthcare professional, such as a doctor or pharmacist.

Healthcare providers should exercise caution when prescribing this medication to geriatric patients, ensuring appropriate monitoring and consideration of potential dose adjustments based on individual health status and response to treatment.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should be aware that this product contains acetaminophen, which carries a risk of severe liver damage. It is critical that patients do not exceed the maximum daily amount of 8 teaspoonfuls (40 mL) within a 24-hour period. Additionally, patients should avoid the concurrent use of other medications containing acetaminophen, as this may further increase the risk of liver injury.

Patients with compromised liver function are advised to consult a healthcare professional prior to using this product, particularly if they have existing health issues, especially liver disease. Consumption of three or more alcoholic drinks daily while using this product is also contraindicated, as it may exacerbate the risk of liver damage.

In the event of an overdose, which may occur if the recommended dose is exceeded, patients must seek immediate medical assistance or contact a Poison Control Center. Prompt medical attention is essential, even if no signs or symptoms of overdose are present, to mitigate the risk of potential liver damage.

Overdosage

In cases of overdose, the administration of doses exceeding the recommended amount may lead to significant liver damage. It is imperative that healthcare professionals advise patients to seek immediate medical assistance or contact a Poison Control Center without delay.

Prompt medical intervention is crucial, even in the absence of noticeable signs or symptoms of overdose. Early recognition and management can mitigate potential complications associated with liver injury. Therefore, vigilance in monitoring and addressing any suspected overdose situations is essential for optimal patient outcomes.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional prior to use.

Acetaminophen has been associated with severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of a skin reaction, it is imperative to discontinue use and seek medical assistance immediately.

No relevant information regarding nonclinical toxicology or animal pharmacology and toxicology is provided in the insert.

Postmarketing Experience

Acetaminophen has been associated with severe skin reactions, as reported in postmarketing surveillance. Symptoms of these reactions may include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use and seek medical assistance immediately.

Additionally, users are instructed to stop use and consult a healthcare professional if new symptoms arise, such as rash, hives, itching, or hoarseness; if redness or swelling occurs; if pain worsens or persists for more than 10 days; if fever intensifies or lasts longer than 3 days; or if symptoms do not improve. These symptoms may indicate a serious condition.

For reporting any adverse reactions, individuals are encouraged to contact the FDA at (888) 463-6332 or visit www.FDA.gov/medwatch.

Patient Counseling

Healthcare providers should advise patients that taking more than the recommended dose of this medication may lead to liver damage. In the event of an overdose, it is crucial to seek medical help or contact a Poison Control Center immediately, as prompt medical attention is essential even if no signs or symptoms are apparent.

Patients should be informed not to use this medication in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they should be encouraged to consult a doctor or pharmacist.

It is important to instruct patients not to use this medication for more than 10 days for pain or more than 3 days for fever unless directed by a healthcare professional. Additionally, patients should be cautioned against using this product if they have a known allergy to acetaminophen or any of the inactive ingredients.

Patients should be advised to stop using the medication and consult a doctor if they experience new symptoms such as rash, hives, itching, or hoarseness. They should also be instructed to seek medical advice if they notice redness or swelling, if their pain worsens or persists beyond 10 days, if their fever worsens or lasts more than 3 days, or if their symptoms do not improve, as these may indicate a serious condition.

While using this product, patients must not exceed the recommended dose, and they should be reminded of the overdose warning. It is advisable for patients to consult a doctor before using this medication if they have any health issues, particularly liver disease. Furthermore, patients should be encouraged to speak with a doctor or pharmacist before use if they are taking other medications, including blood thinners such as warfarin.

Storage and Handling

Dispensed products should be provided in a tight, light-resistant container equipped with a child-resistant cap. The recommended storage temperature is between 20°C and 25°C (68°F to 77°F), with permissible excursions between 15°C and 30°C (59°F to 86°F). Proper adherence to these storage conditions is essential to maintain product integrity and safety.

Additional Clinical Information

Patients aged 12 years and older are advised to take 3 teaspoonfuls (15 mL) every 5 hours, with a maximum of 15 teaspoonfuls (75 mL) in a 24-hour period. For children under 12 years of age, administration should occur only under the direct guidance of a licensed professional, doctor, or pharmacist.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. Additionally, it is important to keep the product out of reach of children. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for M-Pap, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)